News · Option Care Health, Inc. (OPCH) · Healthcare

Option Care Health jumps 32.6% after agreeing to $32.05-per-share buyout

Session of October 6, 2026 · Published October 7, 2026 · 3 min read

What happened

Option Care Health (OPCH) rose 32.6% on October 6, 2026, after agreeing to be acquired for $32.05 per share by buyers that include McKesson and Clayton, Dubilier & Rice. The proposed transaction was reported by The Motley Fool and PRNewsWire. Multiple investor-rights law firms launched investigations into the proposed buyout, questioning whether the $32.05 per-share price is fair and whether deal terms restrict competing offers, Business Wire and GuruFocus reported.

Closing price over the last 30 trading sessions. On October 6, 2026, OPCH closed at $31.00, up 32.6% on the day and 31.1% higher than 30 sessions earlier.

How big was the move

The stock opened 32.8% above the previous close and closed at $31.00 on the session. Trading volume ran 29.5 times its 20-day average, reflecting heavy investor interest. The one-day rise of 32.6% far outpaced broader markets: the S&P 500 rose 0.6% on the day, and the healthcare sector median fell 1.8%, leaving the stock 34.4 percentage points better than the sector median.

Each bar is one day's price change; the outlined bar is October 6, 2026. A typical daily move over the past year was 2.6%, so the latest move equals 12.5 times that. Moves outside the dashed lines (about 5.2%) are unusual.

The change over the last five sessions was a rise of 35.9%, and the session’s magnitude was 7.9 times a typical daily move for this stock. Those metrics point to a large, mostly company-specific move that followed takeover reports and the ensuing legal inquiries. By contrast, the stock’s beta of 0.56 indicates it typically moves less than the market, underscoring how unusual the session was.

The technical picture

Technically, the shares traded well above short- and medium-term averages. The stock was 30.1% above its 20-day moving average and 30.6% above its 50-day moving average, and it sat 17.2% above its 200-day moving average. The 50-day average remained below the 200-day average, which is a sign of a weaker longer-term trend despite the recent surge.

Closing price over the past year. OPCH ends the period 15.3% below its 52-week high, above its 50-day average ($23.75) and above its 200-day average ($26.44).

Momentum indicators also signaled a strong short-term advance. The Relative Strength Index (14 days) reached 84, above the 70 level often called overbought. The shares were 15.8% below their 52-week high despite gains of 28.0% over one month and 44.4% over three months. Over one year the stock rose 12.7%, which was 3.7 percentage points behind the S&P 500. Volatility was elevated, at 65% annualized over 60 days and higher than 95% of its own readings over five years.

Fundamentals and valuation

Over the four quarters through June 30, 2026, Option Care Health reported revenue of $5.69 billion, up 5.9% from a year earlier. Revenue growth one quarter earlier was growth of 9.3%. Diluted earnings per share for that period were $1.33, and earnings per share rose 6.4% from a year earlier. Gross margin was 18.2%, down from 19.1% a year earlier, while operating margin was 5.9%, down from 6.2% a year earlier.

Quarterly revenue by period end. The latest quarter brought $1.4B, 1.9% more than the same quarter a year earlier.

Free-cash-flow margin was 6.1% and return on invested capital was 9.6%. The balance sheet showed net debt of 2.6 times EBITDA, and share count over one year decreased by 5.1%. On valuation, the stock traded at 23.3 times trailing earnings, a level lower than 67% of its own readings over the past five years (five-year median: 25.9 times earnings). Price to forward earnings was 16.5 times expected earnings, and free-cash-flow yield was 10.2%.

PromtFinance scores ranked the company highly for Value at 96 (Exceptional), while Growth scored 45 (Neutral) and Quality scored 64 (Neutral). Revisions were weak at 28 (Very weak), with Momentum at 59 (Neutral) and Stability at 63 (Neutral).

Earnings and analyst expectations

Option Care Health is scheduled to report next on October 29, 2026. The company’s last report, on July 29, 2026, showed earnings per share of $0.45 against $0.43 expected, 5.6% above estimates. That marked two consecutive quarters beating estimates and an average surprise over the last four reports of 4.6% above estimates. Recent typical two-day reactions after earnings releases saw the stock fall 7.4%.

Diluted earnings per share by quarter. The latest quarter shows $0.35, against $0.31 in the same quarter a year earlier.

Analysts’ consensus is Buy, with 73% of the 15 analysts rating the stock Buy or equivalent. The consensus price target was $28.43, which was 8.3% below the closing price.

What to watch

October 29, 2026: next earnings report date.
$32.05 per share: proposed acquisition price reported by The Motley Fool and PRNewsWire.
Investor-rights investigations reported by Business Wire and GuruFocus into the fairness and terms of the proposed buyout.
Trading volume at 29.5 times its 20-day average and session opening 32.8% above the previous close.
Net debt of 2.6 times EBITDA and free-cash-flow yield of 10.2%.

Full OPCH analysis: scores, chart and financials →